Filing Details
- Accession Number:
- 0000905718-19-000596
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-11 16:43:19
- Reporting Period:
- 2019-07-09
- Accepted Time:
- 2019-07-11 16:43:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1130598 | Onconova Therapeutics Inc. | ONTX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1219314 | P L Partners Capital Tyndall | 150 East 58Th Street 14Th Floor New York NY 10155 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-07-09 | 8,185 | $2.84 | 805,249 | No | 4 | S | Indirect | See Note |
| Common Stock | Disposition | 2019-07-10 | 2,742 | $2.81 | 802,507 | No | 4 | S | Indirect | See Note |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See Note |
| No | 4 | S | Indirect | See Note |
Footnotes
- Tyndall Capital Partners, L.P. ("Tyndall Capital") is the general partner of Tyndall Partners, L.P. ("Tyndall"), and possesses the sole power to vote and the sole power to direct the disposition of all securities held by Tyndall. Tyndall Capital's interest in the securities reported herein is limited to the extent of its pecuniary interest in such securities, if any.
Billionaire Hedge Funds
